HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.

about

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.

Item

http://www.wikidata.org/entity/Q41095997

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

HE4 is a novel tissue marker f ...... -risk endometrial hyperplasia.

@en

type

Item

label

HE4 is a novel tissue marker f ...... -risk endometrial hyperplasia.

@en

prefLabel

HE4 is a novel tissue marker f ...... -risk endometrial hyperplasia.

@en

P1476

HE4 is a novel tissue marker f ...... -risk endometrial hyperplasia.

@en

P2093

Anne Ørbo

http://www.w3.org/2001/XMLSchema#string

Bjørn Straume

http://www.w3.org/2001/XMLSchema#string

Christer Borgfelt

http://www.w3.org/2001/XMLSchema#string

Lena Myreng Lyså

http://www.w3.org/2001/XMLSchema#string

Marit Arnes

http://www.w3.org/2001/XMLSchema#string

P2860

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

Proteins with whey-acidic-protein motifs and cancer

Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.

Genetics of endometrial cancers

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.

Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes.

Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.

P2888

bjc.2016.247

P304

725-730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.247

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27537387

http://www.w3.org/2001/XMLSchema#string

P932

5023780

http://www.w3.org/2001/XMLSchema#string